The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zirtek 1 mg/ml oral solution



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/062/001

Main Information

Trade NameZirtek 1 mg/ml oral solution
Active SubstancesCetirizine dihydrochloride
Dosage FormOral solution
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/062/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine

Status

License statusAuthorised
Licence Issued02/06/2023
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back